JPRN-UMIN000016782已完成未知
An exploratory study of treatment sensitivity and prognostic factors in a Phase III, randomized, controlled study comparing the efficacy and safety of mFOLFOX6 + bevacizumab therapy vs. mFOLFOX6 + panitumumab therapy in patients with chemotherapy-naïve wild-type RAS(KRAS/NRAS) unresectable advanced or recurrent colorectal cancer - Exploratory analysis of biomarkers in PARADIGM study
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 757
研究概览
简要总结
A
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1)Patients who are determined by the investigator or researchers to be not suitable for participating in the additional study
研究者
相似试验
已完成
3 期
An exploratory study of treatment sensitivity and prognostic factors in a efficacy and safety study of mFOLFOX6 + bevacizumab versus mFOLFOX6 + panitumumab therapy in patients with chemotherapy-naive unresectable advanced or recurrent colorectal cancerColorectal cancerJPRN-jRCT1080222785Takeda Pharmaceutical Company Limited757
进行中（未招募）
不适用
An Exploratory Study of Treatment Sensitivity and Prognostic Factors in a Efficacy and Safety Study of mFOLFOX6 + Bevacizumab Versus mFOLFOX6 + Panitumumab Therapy in Patients With Chemotherapy-naïve Unresectable Advanced or Recurrent Colorectal CancerColorectal CancerNCT02394834Takeda757
招募中
Unknown
Factors associated with treatment responsiveness and treatment course of Parent-Child Interaction Therapy (PCIT)JPRN-UMIN000049623ational Center of Neurology and Psychiatry30
已完成
不适用
A Study on predictors of treatment response concerning of the efficacy of tolvaptan on refractory ascites.iver cirrhosis with refractory ascites.JPRN-UMIN000026426The third department of internal medicine, Nara Medical University30
招募中
不适用
Study to investigate possible applications for MRI and ultrasound in the diagnosis of atherosclerosis of the carotid artery.NL-OMON26704Academic Medical Center50